Us Bancorp \De\ Corcept Therapeutics Inc Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 19,683 shares of CORT stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,683

Previous 7,506 162.23%

Holding current value

$1.09 Million

Previous $243,000 274.49%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$29.51 - $46.26 $359,343 - $563,308	12,177 Added 162.23%	19,683 $910,000
Q2 2024 Aug 06, 2024	SELL	$22.21 - $34.48 $394,804 - $612,916	-17,776 Reduced 70.31%	7,506 $243,000
Q1 2024 May 07, 2024	BUY	$21.1 - $27.46 $525,052 - $683,314	24,884 Added 6252.26%	25,282 $636,000
Q4 2023 Feb 09, 2024	SELL	$24.82 - $32.88 $744 - $986	-30 Reduced 7.01%	398 $12,000
Q3 2023 Nov 03, 2023	SELL	$21.97 - $33.8 $4,262 - $6,557	-194 Reduced 31.19%	428 $11,000
Q2 2023 Aug 09, 2023	BUY	$21.44 - $25.15 $2,229 - $2,615	104 Added 20.08%	622 $13,000
Q1 2023 May 09, 2023	BUY	$19.2 - $24.47 $4,166 - $5,309	217 Added 72.09%	518 $11,000
Q4 2022 Feb 13, 2023	BUY	$19.95 - $29.96 $1,236 - $1,857	62 Added 25.94%	301 $6,000
Q3 2022 Oct 27, 2022	BUY	$24.7 - $29.12 $3,235 - $3,814	131 Added 121.3%	239 $6,000
Q2 2022 Aug 01, 2022	BUY	$17.33 - $25.3 $675 - $986	39 Added 56.52%	108 $2,000
Q1 2022 May 11, 2022	BUY	$16.53 - $25.21 $1,140 - $1,739	69 New	69 $1,000
Q2 2021 Aug 05, 2021	SELL	$19.97 - $24.43 $1,617 - $1,978	-81 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$23.49 - $30.56 $1,902 - $2,475	81 New	81 $2,000
Q4 2020 Feb 04, 2021	SELL	$16.78 - $27.3 $2,886 - $4,695	-172 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$12.46 - $19.98 $2,230 - $3,576	-179 Reduced 51.0%	172 $3,000
Q2 2020 Aug 07, 2020	BUY	$11.0 - $18.26 $1,892 - $3,140	172 Added 96.09%	351 $6,000
Q2 2019 Aug 13, 2019	BUY	$9.78 - $12.76 $1,750 - $2,284	179 New	179 $2,000
Q1 2019 May 08, 2019	SELL	$10.03 - $15.71 $1,885 - $2,953	-188 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$11.29 - $17.19 $1,117 - $1,701	99 Added 111.24%	188 $3,000
Q3 2018 Nov 01, 2018	BUY	$12.27 - $15.65 $1,092 - $1,392	89 New	89 $1,000
Q2 2018 Aug 08, 2018	SELL	$15.3 - $19.69 $71,114 - $91,519	-4,648 Closed	0 $0
Q1 2018 May 08, 2018	SELL	$14.59 - $25.5 $27,006 - $47,200	-1,851 Reduced 28.48%	4,648 $76,000
Q4 2017 Feb 02, 2018	BUY	$15.77 - $20.72 $2,239 - $2,942	142 Added 2.23%	6,499 $117,000
Q3 2017 Nov 13, 2017	BUY	$12.3 - $19.3 $78,191 - $122,690	6,357	6,357 $123,000

Others Institutions Holding CORT

# of Institutions

347

Shares Held

86.6M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.91B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account